September 13, 2018
- CDER Leadership Bio: Carol Bennett, J.D. Acting Director, Office of Regulatory Policy
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Trials Snapshots: PIFELTRO
- FDA approves Lumoxiti (moxetumomab pasudotox-tdfk), a new kind of treatment for hairy cell leukemia
- FDA Drug Shortages
- Daclatasvir Tablets (New - Discontinuation)
- Testosterone 1% Gel (New - Discontinuation)
- National Drug Code Directory (updated)
- Product-Specific Guidances for Generic Drug Development (updated)
- Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of all Sterile Compounded Drugs Due to A Potential Lack of Sterility Assurance
- Phonetic and Orthographic Computer Analysis (POCA) Program (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario